A Home-based Exercise and Physical Activity Intervention After Liver Transplantation: Impact of Exercise Intensity
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Mar 7, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PHOENIX-Liver study is looking at how different levels of exercise can help people recover after liver transplantation. Researchers want to find out the best intensity of exercise for these patients, so they will divide participants into three groups: low, moderate, and moderate to high intensity. The exercise program will take place at home for six months, but it will be supervised by a trained investigator to ensure safety and effectiveness. Throughout the study, participants will have their physical fitness, heart health, liver function, and body composition checked at the beginning, after three months, and after six months. They will also complete monthly surveys to share how they are feeling and how their quality of life is changing.
To be part of this trial, you must be a new adult liver transplant recipient, about two to three months post-surgery, and have access to a home freezer. There are some conditions that might prevent you from participating, like serious heart or lung issues, current cancer treatment, or not being able to understand Dutch. After the exercise program, there will be an additional 15-month phase where patients can continue a physical activity routine that suits their preferences. Follow-up visits at UZ Leuven will help track progress and health improvements at three and fifteen months after the initial program.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • de novo adult liver transplant recipients with a transplant vintage of two to three months
- • access to a home freezer (± -18°C)
- Exclusion Criteria:
- • Aberrant CPET (abnormal low cardiorespiratory fitness is not considered an exclusion criteria), unstable angina, life-threatening arrhythmias, uncontrolled hypertension/diabetes, HbA1c ≥ 9%, severe pulmonary disease (FEV1 \< 50%), musculoskeletal disorders not allowing physical training on a cycle ergometer, or any other medical reasons by the physician considered to be a contraindication for moderate or high-intensity physical exercise
- • multi-organ transplantation (exception: combined liver-kidney transplant is considered eligible for participation)
- • ongoing treatment for malignancies
- • unable to understand Dutch
- • no access to smartphone and/or computer with internet access
- • does not willing to except the general conditions of Coachbox. Preparticipation medical screening (cardiopulmonary exercise testing with 12-lead ECG + stratification of cardiovascular risk factors) will be performed by a cardiologist (Dr. Kaatje Goetschalckx at UZ Leuven).
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, Vlaams Brabant, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported